looks like no one would like to patiently waiting until 2020+ undertaking numerous funding/development risks for 7 years!Better to stop burning cash in such super-fast way!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%